ACCEPT
Accupril Canadian Clinical Evaluation and Patient Teaching

Purpose
To evaluate the efficacy and safety of the angiotensin converting enzyme (ACE) inhibitor quinapril in hypertension

References
Larochelle P, Harness B, Maroon N, et al: A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT study. Clin Ther 1994, 16:838–853.

Voltar

Apoio: Libbs Farmacêutica Farmacêutica